Muthusamy Shanmugam, HEAD OF R&D, COO-NOVITIUM Operations at ANI PHARMACEUTICALS INC (ANIP), sold 80,000 shares at $65.35 ($5.3M) on 2024-03-05, disclosed to the SEC on 2024-03-07.
Scheduled sale ($5.3M) by HEAD OF R&D, COO-NOVITIUM Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.35 | 10,093 | $660K | 12.5% |
| 2 | $65.35 | 10,093 | $660K | 12.5% |
| 3 | $65.47 | 14,822 | $970K | 18.4% |
| 4 | $65.47 | 14,822 | $970K | 18.4% |
| 5 | $66.35 | 15,085 | $1.0M | 19.0% |
| 6 | $66.35 | 15,085 |
| $1.0M |
| 19.0% |
| Total | $65.77 avg | 80,000 | $5.3M | 100% |
| Filing → |
| ANIP | SELL | 2025-05-13 | $54K | — | Filing → |
| ANIP | SELL | 2024-07-19 | $170K | — | Filing → |
| ANIP | SELL | 2024-07-17 | $3.9M | — | Filing → |